Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival-Reference-Cited by-同舟云学术

Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival

Published:2009-11-16 Issue:11 Volume:4 Page:e7850
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bray Isabella,Bryan Kenneth,Prenter Suzanne,Buckley Patrick G.,Foley Niamh H.,Murphy Derek M.,Alcock Leah,Mestdagh Pieter,Vandesompele Jo,Speleman Frank,London Wendy B.,McGrady Patrick W.,Higgins Desmond G.,O'Meara Anne,O'Sullivan Maureen,Stallings Raymond L.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference24 articles.

1. Neuroblastoma: biological insights into a clinical enigma.;GM Brodeur;Nat Rev Cancer,2003

2. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.;GM Brodeur;Science,1984

3. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.;J Vandesompele;J Clin Oncol,2005

4. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.;R Spitz;Clin Cancer Res,2003

5. Chromosome 1p and 11q deletions and outcome in neuroblastoma.;EF Attiyeh;N Engl J Med,2005

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of non-coding RNAs in neuroblastoma;Cancer Gene Therapy;2023-05-22

2. Neuroblastoma;Epigenetic Cancer Therapy;2023

3. MicroRNAs as prospective biomarkers, therapeutic targets and pharmaceuticals in neuroblastoma;Molecular Biology Reports;2022-12-15

4. A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma;Cancers;2021-11-03

5. Crosstalk between oncogenic MYC and noncoding RNAs in cancer;Seminars in Cancer Biology;2021-10